The Pharmaceutical Care Management Association (PCMA) released the following statement on recently submitted comments to the Centers for Medicare & Medicaid Services (CMS) regarding the Medicare Parts C and D proposed rule and request for information (RFI): “Since its inception,
The Medicare Prescription Drug Rebate Rule PCMA Urges Congress to Permanently Repeal Rebate Rule This Year The Medicare Part D prescription drug benefit provides our nation’s seniors with affordable drug coverage, which is more important now than ever. The rebate
The evidence is clear: prescription drug rebates negotiated by pharmacy benefit companies with drug companies are not correlated with drug list prices, which are set solely by drug companies. A recent analysis using Centers for Medicare and Medicaid Services (CMS)
Pharmacy Benefit Companies Innovate to Provide Choice for Clients, Lower Costs for Patients Even as Congress considers more government intervention and “drug pricing” legislation that ironically may prove only to increase prescription drug costs, pharmacy benefit companies continue to evolve
New Milliman Analysis Shows Medicare Part D Proposed Rule Could Increase Premiums More than It Saves in Cost Sharing for Majority of Beneficiaries
(Washington, D.C.) — Pharmaceutical Care Management Association (PCMA) President and CEO JC Scott issued the following statement on the 2023 Medicare Part D proposed rule from the Centers for Medicare & Medicaid Services (CMS): “We are currently reviewing the proposed rule.
(Washington, D.C.) —Pharmaceutical Care Management Association (PCMA) President and CEO JC Scott issued the following statement on the Energy and Commerce Subcommittee on Health hearing: “Lowering Prescription Drug Prices: Deconstructing the Drug Supply Chain:” “We stand with Congress and the
(Washington, D.C.) —Pharmaceutical Care Management Association (PCMA) President and CEO JC Scott issued the following statement on the Congressional Budget Office’s (CBO) scoring of the Health and Human Services Office of Inspector General’s proposed rule revising the safe harbors around
(Washington, D.C.) — Pharmaceutical Care Management Association (PCMA) President and CEO Mark Merritt released the following statement on the new Health and Human Services (HHS) proposal pending at the Office of Management and Budget (OMB): “Removal Of Safe Harbor Protection for
©2024 PCMA. All Rights Reserved.
